Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Feb 25 | MBX MBX Biosciences, Inc. Common Stock | Common Stock | Buy | Acquire P | Yes | No | 10.84 | 94,100 | 1.02 mm | 747,887 |
18 Feb 25 | MBX MBX Biosciences, Inc. Common Stock | Common Stock | Buy | Acquire P | Yes | No | 10.84 | 49,070 | 531.92 k | 3,255,000 |
14 Feb 25 | MBX MBX Biosciences, Inc. Common Stock | Common Stock | Buy | Acquire P | Yes | No | 9.85 | 29,540 | 290.97 k | 3,205,930 |
14 Feb 25 | MBX MBX Biosciences, Inc. Common Stock | Common Stock | Buy | Acquire P | Yes | No | 9.9 | 17,962 | 177.82 k | 3,176,390 |
11 Feb 25 | CMPX Compass Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.65 | 40,000 | 146.00 k | 40,000 |
1 Nov 24 | Venetian-1 Acquisition | Common Stock | Grant | Acquire A | Yes | No | 4 | 155,120 | 620.48 k | 2,677,256 |
1 Nov 24 | Venetian-1 Acquisition | Common Stock | Grant | Acquire A | Yes | No | 4 | 479,736 | 1.92 mm | 2,522,136 |
1 Nov 24 | Venetian-1 Acquisition | Common Stock | Grant | Acquire A | Yes | No | 4 | 808,894 | 3.24 mm | 2,042,400 |
1 Nov 24 | Venetian-1 Acquisition | Common Stock | Conversion | Acquire C | Yes | No | 3.6 | 74,613 | 268.61 k | 1,233,506 |
1 Nov 24 | Venetian-1 Acquisition | Common Stock | Conversion | Acquire C | Yes | No | 3.6 | 230,753 | 830.71 k | 1,158,893 |